Chaim Sheba Medical Center at Tel HaShomer, also Tel HaShomer Hospital, is the largest hospital in Israel, located in the Tel Aviv District city of Ramat Gan at Tel HaShomer neighborhood, Israel. In 2020, Newsweek ranked it as the 9th-best hospital in the world.

There are 1,580 beds in Sheba Medical Center - PPDS.

During the past decade, Sheba Medical Center - PPDS conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 5 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 5 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sheba Medical Center - PPDS" #1 sponsor was "Takeda" with 4 trials, followed by "Genentech, Inc." with 3 trials sponsored, "Merck Sharp & Dohme LLC" with 3 trials sponsored, "Nektar Therapeutics" with 2 trials sponsored and "Shire" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sheba Medical Center - PPDS" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Sheba Medical Center - PPDS" are "Prostatic Neoplasms" (3 trials), "Hereditary Angioedema (HAE)" (2 trials), "Advanced Solid Tumors" (1 trials), "Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)" (1 trials) and "Autologous Stem Cell Transplant" (1 trials). Many other conditions were trialed in "Sheba Medical Center - PPDS" in a lesser frequency.

Most popular intervention types in "Sheba Medical Center - PPDS" are "Drug" (12 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Pembrolizumab" (3 trials), "Bempegaldesleukin" (2 trials), "Enzalutamide" (2 trials) and "Nivolumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sheba Medical Center - PPDS" are 15 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Sheba Medical Center - PPDS". undefined are not yet recruiting, 6 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Sheba Medical Center - PPDS, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sheba Medical Center - PPDS, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".